167 related articles for article (PubMed ID: 20437090)
1. Tamoxifen and raloxifene modulate gap junction coupling during early phases of retinoic acid-dependent neuronal differentiation of NTera2/D1 cells.
Dahm L; Klugmann F; Gonzalez-Algaba A; Reuss B
Cell Biol Toxicol; 2010 Dec; 26(6):579-91. PubMed ID: 20437090
[TBL] [Abstract][Full Text] [Related]
2. Reduction of connexin43 expression and dye-coupling during neuronal differentiation of human NTera2/clone D1 cells.
Bani-Yaghoub M; Bechberger JF; Naus CC
J Neurosci Res; 1997 Jul; 49(1):19-31. PubMed ID: 9211986
[TBL] [Abstract][Full Text] [Related]
3. The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.
Williams-Brown MY; Salih SM; Xu X; Veenstra TD; Saeed M; Theiler SK; Diaz-Arrastia CR; Salama SA
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):78-86. PubMed ID: 21600284
[TBL] [Abstract][Full Text] [Related]
4. The effects of gap junction blockage on neuronal differentiation of human NTera2/clone D1 cells.
Bani-Yaghoub M; Bechberger JF; Underhill TM; Naus CC
Exp Neurol; 1999 Mar; 156(1):16-32. PubMed ID: 10192774
[TBL] [Abstract][Full Text] [Related]
5. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation.
Nalbandian G; Paharkova-Vatchkova V; Mao A; Nale S; Kovats S
J Immunol; 2005 Aug; 175(4):2666-75. PubMed ID: 16081843
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
Todorova VK; Kaufmann Y; Luo S; Klimberg VS
Cancer Chemother Pharmacol; 2011 Feb; 67(2):285-91. PubMed ID: 20383709
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries.
Yoshikawa Y; Miyashita T; Higuchi S; Tsuneyama K; Endo S; Tsukui T; Toyoda Y; Fukami T; Nakajima M; Yokoi T
Toxicol Appl Pharmacol; 2012 Oct; 264(1):42-50. PubMed ID: 22841776
[TBL] [Abstract][Full Text] [Related]
8. Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo.
Eigeliene N; Kangas L; Hellmer C; Kauko T; Erkkola R; Härkönen P
Menopause; 2016 Jul; 23(7):719-30. PubMed ID: 27163517
[TBL] [Abstract][Full Text] [Related]
9. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
10. Neuronal differentiation requires a biphasic modulation of gap junctional intercellular communication caused by dynamic changes of connexin43 expression.
Lemcke H; Nittel ML; Weiss DG; Kuznetsov SA
Eur J Neurosci; 2013 Jul; 38(2):2218-28. PubMed ID: 23607708
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.
Yang R; Ma YX; Chen LF; Zhou Y; Yang ZP; Zhu Y; Du XL; Shi JD; Ma HS; Zhang J
Asian J Androl; 2010 Sep; 12(5):735-43. PubMed ID: 20473319
[TBL] [Abstract][Full Text] [Related]
12. Differential connexin expression, gap junction intercellular coupling, and hemichannel formation in NT2/D1 human neural progenitors and terminally differentiated hNT neurons.
Boucher S; Bennett SA
J Neurosci Res; 2003 May; 72(3):393-404. PubMed ID: 12692906
[TBL] [Abstract][Full Text] [Related]
13. Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells.
Barsalou A; Dayan G; Anghel SI; Alaoui-Jamali M; Van de Velde P; Mader S
Mol Cell Endocrinol; 2002 Apr; 190(1-2):65-73. PubMed ID: 11997179
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Ishihara Y; Itoh K; Ishida A; Yamazaki T
J Steroid Biochem Mol Biol; 2015 Jan; 145():85-93. PubMed ID: 25305410
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat.
Pinilla L; Barreiro ML; Gonzalez LC; Tena-Sempere M; Aguilar E
J Endocrinol; 2002 Mar; 172(3):441-8. PubMed ID: 11874692
[TBL] [Abstract][Full Text] [Related]
17. Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.
de Araujo LF; Grozovsky R; dos Santos Pereira MJ; de Carvalho JJ; Vaisman M; Carvalho DP
Thyroid; 2010 Jan; 20(1):85-92. PubMed ID: 20017619
[TBL] [Abstract][Full Text] [Related]
18. Increased antitumor potential of the raloxifene prodrug, raloxifene diphosphate.
Okamoto Y; Liu X; Suzuki N; Okamoto K; Sekimoto M; Laxmi YR; Shibutani S
Int J Cancer; 2008 May; 122(9):2142-7. PubMed ID: 18183587
[TBL] [Abstract][Full Text] [Related]
19. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens.
Heikaus S; Winterhager E; Traub O; Grümmer R
J Mol Endocrinol; 2002 Oct; 29(2):239-49. PubMed ID: 12370124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
